| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022326 Nucleotide sequences coding polypeptide for use in tumor therapy |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022314 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 01/30/2003 | US20030022313 Novel neuronal cell growth factor |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022305 Nucleotide sequences coding polypeptide for use in the detection of modulators and herbicides |
| 01/30/2003 | US20030022303 Expression vector for use in the treatment of blood disorders |
| 01/30/2003 | US20030022291 Production of a multimeric protein by cell fusion method |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/30/2003 | US20030022287 Non aggregating fluorescent proteins and methods for using the same |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 01/30/2003 | US20030022278 T2R, a novel family of taste receptors |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022276 Dendritic enriched secreted lymphocyte activation molecule |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022272 Method of inducing an antigen-specific anticytotoxic cell |
| 01/30/2003 | US20030022262 Methods of detecting early renal disease in animals |
| 01/30/2003 | US20030022253 Method for identifying, isolating and producing neuroactive binding agents and binding agents derived thereby |
| 01/30/2003 | US20030022249 Culturing dendritic cells; obtain cell pools, incubate with affinity column, elute, recover preferential cells |
| 01/30/2003 | US20030022241 Detection of modulators of enzyme activity; obtain sample containing kinase activity, incubate with modulator, monitor diabetic response |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022228 Amplification of membrane maintenance and suppression of hemolysis of stored blood; obtain blood sample, incubate with support solution, monitor erythrocyte and platelet stability |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022210 Induction of tissue repair and/or regeneration; obtain cells, incubate with lymphocytes, monitor regeneration of tissues |
| 01/30/2003 | US20030022202 Amino acid sequences for use in the treatment of inflammation and autoimmune diseases |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022185 Secreted protein HLHFP03 |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030022179 Methods and reagents for molecular cloning |
| 01/30/2003 | US20030022178 Identification of sortase gene |
| 01/30/2003 | US20030022171 Detection of modulator of amyloid precursor protein cleavage; obtain cells, incubate with modulator, detect adjustment in amyloid precursor protein, adjustment in protein indicates modulator |
| 01/30/2003 | US20030022159 Method for identifying intercellular protein factors |
| 01/30/2003 | US20030021827 Hybrid biologic/synthetic porous extracellular matrix scaffolds |
| 01/30/2003 | US20030021796 Method of enhancing T cell immunity by selection of antigen specific T cells |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021781 Administering antibodies |
| 01/30/2003 | US20030021779 Immunology response; monoclonal antibodies |
| 01/30/2003 | US20030021775 Control activation using enzymes; therapy for skin defects |
| 01/30/2003 | US20030021771 Osteoblast precursors from human embryonic stem cells |
| 01/30/2003 | US20030021767 Recombinant p53 adenovirus methods and compositions |
| 01/30/2003 | CA2454873A1 Novel transformed cell, method for screening anti-aging agent, and anti-aging agent |
| 01/30/2003 | CA2454563A1 Glucans and glucansucrases derived from lactic acid bacteria |
| 01/30/2003 | CA2454427A1 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | CA2454185A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453959A1 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 01/30/2003 | CA2453662A1 Modification of human variable domains |
| 01/30/2003 | CA2453428A1 Plant ion channels and methods |
| 01/30/2003 | CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | CA2452653A1 Silencing of gene expression by sirna |
| 01/30/2003 | CA2452518A1 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | CA2450683A1 Tissue engineered heart valve |
| 01/29/2003 | WO2002010350A1 Method of proliferating natural killer cells |
| 01/29/2003 | EP1279739A1 Recombinant vectors derived from adeno-associated virus expressing TAM67 for gene therapy |
| 01/29/2003 | EP1279729A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors |
| 01/29/2003 | EP1279728A1 Generation of fully mature and stable dentritic cells from leukapheresis products for clinical applications |
| 01/29/2003 | EP1279412A2 Pressure-mediated intracellular delivery of molecules of microparticles |
| 01/29/2003 | EP1279332A2 Transgenic non-human mammal |
| 01/29/2003 | EP1279038A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha |
| 01/29/2003 | EP1278886A2 Sigma binding region of rna polymerase and uses thereof |
| 01/29/2003 | EP1278884A1 Immunoglobulin binding protein arrays in plant cells |
| 01/29/2003 | EP1278878A2 Codon optimisation for expression in retrovirus packaging cells |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278871A2 Human phospholipase c delta 5 |
| 01/29/2003 | EP1278870A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
| 01/29/2003 | EP1278867A2 Hcv ns2/3 fragments and uses thereof |
| 01/29/2003 | EP1278866A2 Serine-threonine kinase |
| 01/29/2003 | EP1278864A2 Serine-threonine kinase-3 |
| 01/29/2003 | EP1278863A2 Human serine-threonine kinase-4 |
| 01/29/2003 | EP1278859A2 Human protein kinases and protein kinase-like enzymes |
| 01/29/2003 | EP1278856A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 01/29/2003 | EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278848A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 01/29/2003 | EP1278847A1 New gtpase-activating protein 1 |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278839A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278827A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/29/2003 | EP1278825A2 Methods of producing membrane vesicles |
| 01/29/2003 | EP1278824A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 01/29/2003 | EP1278823A2 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof |
| 01/29/2003 | EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278774A2 Human g-protein coupled receptors |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |